Health Canada drug identification number

DIN 02531925 — KERENDIA 20 MG

KERENDIA is a tablet of Finerenone marketed by BAYER INC. The full Finerenone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02531925
Brand name
KERENDIA
Active ingredient
Finerenone
Strength
20 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
BAYER INC
Health Canada status
MARKETED
Drug class
Nonsteroidal mineralocorticoid receptor antagonist

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Finerenone products

DINBrandStrengthFormManufacturerStatus
02531917 KERENDIA 10 MG TABLET BAYER INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.